Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18024865

Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 Nov 20
First author
Cannistra SA

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2008 Apr 1;26(10):1773
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2007 Nov 20;25(33):5150-2. doi: 10.1200/JCO.2007.13.6150.
    note
    Source null
    related pmid
    18024860
    relationship
    Comment in

Authors and identifiers

  1. name
    Cannistra SA
    type
    Author
  2. name
    Matulonis UA
    type
    Author
  3. name
    Penson RT
    type
    Author
  4. name
    Hambleton J
    type
    Author
  5. name
    Dupont J
    type
    Author
  6. name
    Mackey H
    type
    Author
  7. name
    Douglas J
    type
    Author
  8. name
    Burger RA
    type
    Author
  9. name
    Armstrong D
    type
    Author
  10. name
    Wenham R
    type
    Author
  11. name
    McGuire W
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cannistra SA
    type
    Author
  2. name
    Matulonis UA
    type
    Author
  3. name
    Penson RT
    type
    Author
  4. name
    Hambleton J
    type
    Author
  5. name
    Dupont J
    type
    Author
  6. name
    Mackey H
    type
    Author
  7. name
    Douglas J
    type
    Author
  8. name
    Burger RA
    type
    Author
  9. name
    Armstrong D
    type
    Author
  10. name
    Wenham R
    type
    Author
  11. name
    McGuire W
    type
    Author
bibliography ids
  1. nci-bib-4139a617bd67e38db77ae536
book metadata
content sha256
0298c49392c4882ad5588a77fc05ddced03fdf06bf8955b2a13e9f7f99100de0
document type
citation
dois
  1. 10.1200/JCO.2007.12.0782
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:18024865
immutable id
pubmed:18024865@0298c49392c4882ad5588a77fc05ddced03fdf06bf8955b2a13e9f7f99100de0
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
33
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
5180-6
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2008 Apr 1;26(10):1773
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2007 Nov 20;25(33):5150-2. doi: 10.1200/JCO.2007.13.6150.
    note
    Source null
    related pmid
    18024860
    relationship
    Comment in
outcomes validated
false
pmid
18024865
provenance
batch id
89a0f2206e11ca092d02
provider
NCBI PubMed ESummary
record sha256
99d03a997c1ac13efcd0dd7a9d225c45e05d015f49bd942521a8f177a728b4b2
response sha256
7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
retrieved at
2026-09-09T23:46:16.784581+00:00
publication date
display
2007 Nov 20
precision
day
year
2007
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/18024865/
title
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer.

Preserved source evidence · Not medical advice